Introduction
If you're planning to bring a medical device into Australia, you've probably searched for a "medical device import licence." Here's the issue: no single licence like that exists.
Lawful importation depends on several moving parts:
- Device risk classification
- Therapeutic Goods Administration (TGA) requirements
- Inclusion in the Australian Register of Therapeutic Goods (ARTG)
- Sponsor arrangements
- Customs compliance
This guide is for overseas manufacturers, Australian importers, distributors, clinics, and businesses planning to commercially import medical devices into Australia.
You'll also hear terms like "TGA approval," "ARTG registration," "import approval," and "FDA approval" used as if they mean the same thing. They don't. We'll walk through what each one actually means, the decision points that matter, and where businesses commonly go wrong.
Key Takeaways
- ARTG inclusion is required before commercial supply, unless a TGA exclusion or exemption applies.
- Overseas manufacturers need an Australian sponsor to manage TGA obligations.
- Classification, evidence, labelling, and GMDN coding determine which pathway applies.
- FDA clearance or CE marking can support an application but never replace ARTG inclusion.
- Clearing customs does not authorise commercial supply or use in Australia.
What Medical Device Import Licensing Means in Australia
Australia's regulatory framework centres on two bodies. The Therapeutic Goods Administration (TGA) regulates medical devices sold or used in Australia. The Australian Register of Therapeutic Goods (ARTG) is the public database listing goods authorised for lawful supply.
Most devices need ARTG inclusion before commercial supply, unless an exclusion, exemption, or special pathway applies.
Importing a device isn't the same as supplying it, advertising it, distributing it, or using it clinically. Each activity carries its own obligations:
- Importing brings the device across the border.
- Supplying includes selling, distributing, or even administering a device to a patient during treatment.
- Advertising has its own separate compliance rules under the TGA's advertising code.
- Manufacturing - including relabelling or repackaging - can trigger additional obligations.
A clinic that imports a device and uses it on patients is "supplying" that device, not merely receiving a parcel.
Is It Even a Medical Device?
Not every imported product fits the legal definition. Intended purpose, therapeutic claims, and the product's principal mode of action determine whether something is a medical device, a medicine, a cosmetic, or a borderline product.
A skin-tightening device marketed with therapeutic claims gets treated very differently from identical hardware sold as a beauty gadget with no medical claims.
ARTG Inclusion vs Conformity Assessment vs Sponsor vs Customs Clearance
These four terms get confused constantly:
- ARTG inclusion - the market-entry step confirming a specific device can be lawfully supplied.
- Conformity assessment - evidence that the manufacturer and device meet applicable safety and performance requirements.
- Australian sponsor - the local entity responsible for managing TGA obligations.
- Customs clearance - a border process confirming the shipment meets import declaration requirements. It says nothing about commercial supply rights.
A handful of exceptions exist, including excluded or exempt products, personal importation, clinical trial pathways, and custom-made devices. None of these are general commercial import routes - they apply under narrow, defined conditions only.
Why TGA and ARTG Compliance Is Used for Medical Device Imports
The TGA's framework exists to manage safety, performance, quality, and traceability - both before a device reaches the market and long after it's in use. Post-market monitoring, recall capability, and adverse-event tracking depend on knowing exactly who imported what, and who's responsible for it.
Skipping ARTG compliance carries real consequences. According to the TGA's compliance and enforcement guidance, measures include infringement notices, civil penalty applications, criminal proceedings, recalls, and suspension or cancellation of an ARTG entry.
Suspended goods cannot be imported or supplied while the suspension applies.
Beyond formal regulatory action, non-compliance creates:
- Shipment delays or detained stock at the border
- Forced corrective action or product recalls
- Strained relationships with distributors and clinics
- Insurance complications if a device is used outside its authorised status
Those commercial risks sit alongside a common misconception: that clearance elsewhere is enough for Australia.
Overseas Approval Isn't a Free Pass
An FDA clearance or CE mark reflects compliance with a different regulator's requirements, not Australia's. The TGA may accept certain overseas evidence under its Comparable Overseas Regulator framework, but only for specified device categories, and only alongside an Australian sponsor's own ARTG application.
A device cleared overseas for one use isn't automatically cleared here for a different one.
Other Checks That Can Apply
TGA approval isn't always the only hurdle. Depending on the device, you may also need:
- Electrical safety standards for powered devices
- Radiation safety rules enforced by ARPANSA or state/territory regulators
- Workplace health and safety requirements
- Australian Consumer Law restrictions on misleading claims
- State or territory licensing for certain device categories
How the Import and ARTG Process Works
The pathway runs from product assessment through to ongoing supply. Here's the sequence most businesses follow.
Step 1: Confirm Whether the Product Is Regulated
Compare the product's intended purpose and claims against the TGA's device definition. This matters most for borderline categories:
- Software-based products (medical device or wellness app?)
- In-vitro diagnostics (IVDs)
- Beauty and aesthetic devices carrying therapeutic claims
- General wellness products with no therapeutic claims
Getting this wrong at the start cascades into every later decision.
Step 2: Determine Classification and Conformity Pathway
Australia classifies non-IVD devices as Class I, IIa, IIb, or III, based on risk. Active implantable devices, once labelled "Class AIMD," have been Class III since 25 November 2021 and are no longer a separate category.
IVDs use a different scale: Class 1 to 4, reflecting personal and public-health risk.
Your overseas classification won't automatically transfer. A device classified one way in the EU or US may sit in a different Australian class, with different evidence requirements attached.
Step 3: Appoint an Australian Sponsor Where Required
The sponsor is the Australian-based legal entity that submits the ARTG application, communicates with the TGA, holds manufacturer evidence, and manages vigilance obligations, including recalls.
An overseas manufacturer without an Australian presence needs an eligible local sponsor to pursue inclusion. Each sponsor needs its own ARTG entry, even for a device another company has already included.
Step 4: Prepare Evidence and Apply for ARTG Inclusion
This is the most document-heavy step. Expect to assemble:
- Australian Declaration of Conformity (not a European directive declaration)
- Essential Principles evidence covering safety and performance
- Technical documentation and risk-management files
- Clinical or performance evidence, where relevant
- Compliant labelling and instructions for use
- Manufacturer details and GMDN code
- Overseas conformity evidence, where accepted
Step 5: Import and Maintain Compliance
Once inclusion is confirmed, importing becomes a practical exercise: customs declarations, shipment records, and consistency between the physical product, its labelling, and its ARTG entry. Duties and taxes apply as with any commercial import.
Compliance doesn't end at the border. Ongoing obligations include adverse-event monitoring, distribution record-keeping, and coordinating any recall or corrective action the TGA or manufacturer requires.
Where Medical Device Import Requirements Apply
These requirements show up across a range of business models:
- Overseas manufacturers selling through Australian distributors
- Direct-to-clinic imports
- Wholesalers and e-commerce sellers
- Contract manufacturing arrangements
- Devices used to deliver a treatment or service, such as aesthetic or diagnostic clinics
Obligations also follow the product lifecycle, not just the first shipment:
- Pre-import review and border clearance
- Warehousing and commercial supply
- Advertising, installation, and servicing
- Complaint handling and recall management
Some of these are one-time steps. Others run continuously. An ARTG application is typically a market-entry action. Sponsor record-keeping, adverse-event handling, advertising compliance, and technical-file maintenance continue for as long as the device stays on the market.
Checklist Before You Order
Before placing a purchase order, confirm:
Product and regulatory
- Manufacturer identity and location
- Model and product specifications
- Intended purpose and claims
- Risk classification
- Conformity assessment evidence
- ARTG status, if applicable
- Labelling and instructions for use
Commercial arrangements
- Sponsor arrangements
- Warranty and servicing terms
- Insurance coverage
Key Factors That Determine Compliance
Several variables shape which pathway applies to your device, and how much evidence you'll need to gather.
- Device characteristics and intended purpose - Invasiveness, duration of use, active or implantable functions, diagnostic purpose, and software functionality drive classification and evidence depth.
- Manufacturer evidence and quality systems - Conformity assessment, Essential Principles evidence, risk-management files, and clinical or performance data scale with device class.
- Sponsor and supply-chain structure - ARTG holder, importer, distributor, and record-keeper roles set who handles notifications, complaints, recalls, and product changes.
- Labelling, advertising, and product consistency - English-language information, sponsor details, instructions, and claims must match the approved intended purpose and the model actually assessed.
- Overseas regulatory status - FDA, EU, Health Canada, Japanese, or Singaporean evidence may support a TGA application under the Comparable Overseas Regulator framework only when device, design, intended purpose, and indications match exactly. It remains supporting evidence only.
- Customs and local operational controls - Australian Border Force documentation, electrical or radiation safety, workplace rules, state or territory licensing, servicing, and insurance.
Common Issues and When Importing May Not Be Appropriate
"Customs Clearance Equals Approval" - and Other Myths
Passing through customs confirms your shipment met border requirements. It says nothing about whether you can legally advertise, supply, or use that device commercially.
Other recurring mistakes:
- Treating FDA clearance or a CE mark as automatic Australian authorisation
- Using another company's ARTG entry for your own imports
- Selecting the wrong classification or GMDN code
- Relying on a sponsor with no real connection to the device or manufacturer
- Importing before confirming the manufacturer will actually cooperate with evidence requests
Personal Importation Isn't a Business Workaround
The TGA's Personal Importation Scheme covers goods for personal or immediate-family use only, not resale, clinic stock, or salon treatments.
Current limits cap imports at roughly a three-month supply per shipment, and around 15 months' worth over any 12-month period. Health professionals using a device in clinical practice fall outside this scheme entirely.
When to Pause and Get Advice
Direct importing may not be the right move when:
- Technical documentation isn't available
- Manufacturer identity or cooperation is unclear
- Regulatory claims can't be verified
- No Australian sponsor pathway exists
- Servicing or insurance arrangements are uncertain
- Device claims don't match its assessed intended purpose
Pause before ordering if the product is borderline, high-risk, software-based, implantable, diagnostic, energy-based, or meant for commercial treatment. Get specialist regulatory advice, or contact the TGA directly, first.
Conclusion
Medical device import compliance in Australia is a coordinated process. It covers:
- Product status and classification
- Evidence and sponsor obligations
- ARTG inclusion where required
- Customs clearance and post-market responsibilities
Don't rely on a supplier's claim that a product is "FDA approved," "CE certified," or "already sold in other markets." Verify the device and your supply model against current TGA requirements before you place an order.
Once your regulatory pathway is confirmed, the business side still needs attention: entity setup, tax registration, payroll, and ongoing compliance.
VJM Global supports eligible businesses of any origin, including Australian-domiciled companies, with entity formation, accounting, tax compliance, and business administration across Australia. We don't act as a TGA sponsor or regulatory authority. Once your compliance pathway is clear, we can help with the operational and financial side of running your Australian business.
Frequently Asked Questions
Can I import medical devices into Australia?
Yes, but commercial supply generally requires TGA compliance first: ARTG inclusion or an applicable pathway, sponsor arrangements, and customs clearance. Importation alone doesn't authorise sale or clinical use.
Does Australia have a 25-year import rule?
No. Australia has no general 25-year rule authorising medical device imports. That type of rule applies to some other goods categories, not TGA-regulated devices.
Does Australia use FDA approval?
No. Australia runs its own TGA and ARTG framework. FDA evidence can support certain applications under recognised overseas-regulator pathways, but it doesn't automatically authorise Australian supply.
Do I need an Australian sponsor to import a medical device?
Overseas manufacturers without an Australian presence generally need an eligible Australian sponsor to manage TGA obligations. If your commercial structure differs, confirm it against current TGA sponsor rules.
Does every imported medical device need ARTG inclusion?
Most do, before they can be supplied in Australia. Exclusions, exemptions, clinical trial routes, and special access pathways exist, but only under defined conditions, not as general commercial alternatives.
